Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin vs Atorvastatin on HbA1c in Chinese Patients (CAMPUS)
NCT03532620Phase 4Unknown
- Start
- Aug 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pitavastatin in dyslipidemia (2 arms). Primary endpoint: Hemoglobin A1c at 12 months. Status: unknown.
02
Drugs
pitavastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT03532620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03532620.